Healthcare redefined

Our pro-active patient engagement model and advanced suite of pharmacy services has been designed to reduce readmission risk, decrease adverse health events, lower costs, increase adherence, and  improve overall patients' journey.

Download investor presentation
image of a pharmco r x pharmacist delivering medications
Sign up illustration
01
Integrated Healthcare Solutions for healthier patients

Our patients can now sign up to the dashboard at pharmcorx.com and easily access a complete overview of their medical records including COVID-19 testing, vaccines, doctor visits, medications, radiology, vitals, and more!

02
Successful COVID-19 approach

Our locations are ready to offer a contactless, fast, and secure way to test. Thousands of patients in Florida trust PharmcoRx COVID-19 testing capabilities for traveling or work-related purposes. Schedule a test now!

covid 19 testing
prescriber reporting platform for medication therapy management
03
Enhanced Reporting Capabilities

Prescribers must keep up to the highest quality standards measured by health plan organizations. In order to keep this scores at a maximum they count with ClearMetrX reporting capabilities. Medication adherence, cost containment, and brand to generic ratio are just some of the insights doctors use every day to manage their practices

04
FREE Pharmacy delivery

We provide free same-day delivery for over 40,000 prescriptions a month. We're simplifying the life of our patients with innovative solutions to help them stay on track. Check out our latest adventures on Instagram including our medication filling robots, COVID-19 testing visits, and day-to-day operations.

smart pack medication management system
05
Locations to cover most of the State of Florida.

Miami, Hallandale Beach, Palm Beach, and Orlando are now enjoying full service coverage. click here for more information about our locations and hours of operations.

medication delivery locations in florida
investor relations
06
Investor Relations

Click here to download our investor presentation to learn more about the company.

About Progressive Care Inc.

At Progressive Care, our mission is to improve every step of the patient journey by adding value to prescribers, caregivers, and patients in a seamless manner. Through the implementation of proven processes, we empower medical practices to achieve the highest standards of personalized care. Learn more about us

Products, services and their markets

pharmco-rx-pharmacy

At PharmCo, we take pride in being more than your average pharmacy. We are committed to providing effective, timely, and affordable medications to our patients and the surrounding communities, but our devotion to this mission goes above and beyond.
Learn more about our pharmacy operations

ClearMetrx

ClearMetrX is a full-stack reporting platform that simplifies data analytics for physicians, MSO organizations, 340B entities, and pharmacies.
Learn more about our data management solutions

press releases

Releases

Progressive Care Announces Appointment of Two New Board Members to the Company’s Board of Directors
December 22, 2021
Progressive Care Inc. Announces Results of Special Meeting
December 9, 2021
Progressive Care Engages ClearThink to Lead Expanded Investor Relations Program
November 30, 2021
event calendar

Events

Progressive Care Engages ClearThink to Lead Expanded Investor Relations Program
November 30, 2021
Progressive Care Announces Full Launch of New COVID-19 Digital Passport App
July 20, 2021
Progressive Care, Inc. Announces Results of Special Meeting
December 17, 2020
company earnings

Earnings

Progressive Care Reports Financial and Operational Highlights for Three and Nine Months Ended September 30, 2021
November 16, 2021
Progressive Care Announces Financial and Operational Performance for Three and Six Months Ended June 30, 2021
August 17, 2021
Progressive Care to Announce Second Quarter 2021 Financial Results and Provide Business Update
August 12, 2021
News Releases
Progressive Care Announces Record December and Full Year 2020 Performance Data
Progressive Care Announces Record December and Full Year 2020 Performance Data
MIAMI, FL – February 8, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to report performance data for the month of December and the full year of 2020, which featured robust growth in sales and prescriptions, as well as breakout growth in emerging income streams, including 340B administration fees and COVID-19 Rapid Testing services.
February 8, 2021
Progressive Care Completes Expansion, Launches COVID-19 Rapid Testing at New Orlando Location
Progressive Care Completes Expansion, Launches COVID-19 Rapid Testing at New Orlando Location
MIAMI, FL – February 1, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that its new 3,700 square foot Orlando pharmacy has now officially opened for business as a potent full-service location that is also expected to act as a growth hub for rapid results viral testing services, Covid-19 vaccinations, and 340B third-party administration contracting.
February 1, 2021
Progressive Care Announces November 2020 Results, Reports Strong Prescriptions and Covid-19 Rapid Testing Sales
Progressive Care Announces November 2020 Results, Reports Strong Prescriptions and Covid-19 Rapid Testing Sales
MIAMI, FL – January 8, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of November 2020.
January 7, 2021
Progressive Care Completes Move to New Facility, Begins Expansion Into Long-Term Care Pharmacy Market
Progressive Care Completes Move to New Facility, Begins Expansion Into Long-Term Care Pharmacy Market
Miami, FL – December 23, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has completed its move into its new 11,000 sq ft pharmacy space in Hallandale Beach, FL.
December 23, 2020
Progressive Care, Inc. Announces Results of Special Meeting
Progressive Care, Inc. Announces Results of Special Meeting
MIAMI, FLORIDA - December 17, 2020 - On December 14, 2020, Progressive Care, Inc. (the “Company”) held a special meeting of its stockholders (the “Special Meeting”). The record date for stockholders entitled to notice of, and to vote at, the Special Meeting was October 23, 2020. At the close of business on that date, the Company had 470,272,862 shares of common stock, par value $0.0001 (“Common Stock”) outstanding and 51 shares of Series A Super-Voting preferred stock (“Preferred Stock”) outstanding, and entitled to be voted at the Special Meeting. At the Special Meeting, the following four proposals were submitted to the Company’s stockholders:
December 17, 2020
Progressive Care Announces October Growth in Net Revenues as COVID-19 Testing Ramps Up
Progressive Care Announces October Growth in Net Revenues as COVID-19 Testing Ramps Up
MIAMI, FL – December 7, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of October, which featured a strong jump in operating margins, significant sequential monthly growth in net revenues, and the establishment of sales growth related to rapid results COVID-19 testing.
December 7, 2020
Progressive Care Leadership Announces Shareholder Conference Call and Business Update on December 7th, 2020
Progressive Care Leadership Announces Shareholder Conference Call and Business Update on December 7th, 2020
‍On the call, RXMD management will answer pre-submitted questions and discuss details regarding the recently filed proxy statement.MIAMI, December 3nd 2020 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, December 7th, 2020.
December 3, 2020
Progressive Care Announces Confidential Submission of Draft Registration Statement
Progressive Care Announces Confidential Submission of Draft Registration Statement
MIAMI, FL – December 2nd, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”) is pleased to announce that on November 9th it confidentially submitted a draft Registration Statement on Form S-1 to the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to take place after the SEC completes its review process, subject to market and other conditions.
December 2, 2020
Progressive Care Reports Positive Q3 EBITDA and Increased Margins
Progressive Care Reports Positive Q3 EBITDA and Increased Margins
MIAMI, FL – November 17, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the three months ended September 30, 2020, including strong topline and bottom line growth, positive EBITDA, increased margins, and continued strong cash resources on hand at the close of the quarter.
November 17, 2020
Progressive Care Announces Nine-Month Sales of $30.2 Million, Increase of 31% And Updates September Performance
Progressive Care Announces Nine-Month Sales of $30.2 Million, Increase of 31% And Updates September Performance
MIAMI, FL – November 4, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce preliminary topline performance data for the three- and nine month periods ended September 30, 2020, reflecting strong overall growth in sales and prescriptions, breakout expansion in the Company’s 340B segment, and anticipated progress towards the launch of telemedicine services before year-end.
November 5, 2020